| Intratect® |
Human
normal immunoglobulin for intravenous
use (IVIg) |
|
 |
|
| Indicated
for |
Recommended
Dosage
|
Primary
antibody deficiency
syndromes
|
initially
0.4 - 0.8 g/kg
body weight |
| |
|
Secondary
antibody deficiency
syndromes
and recurrent
bacterial
infections |
0.2-0.4g/kg
every 3-4 weeks
to ensure an
IgG serum level
of 4-6 g/I |
| |
|
AIDS
in children |
0.2-0.4
g/kg every 3-4
weeks
|
| |
|
Allogeneic
bone marrow
transplantation
|
0.5
g/kg weekly,
begin at day-7
before and up
to 3 months
after transplantation
|
| |
|
Idiopathic
thrombocytopenic
purpura(ITP) |
doses
of 0.4 g/kg/d
for 2-5 days |
| |
|
Guillain-Barre
syndrome
|
doses
of 0.4 g/kg/d
for 3-7 days |
| |
|
| Kawasaki
syndrome |
1.6-2
g/kg as a single
dose or divided
over 2-5 days |
|
|
More... |
| |
|
|
|
|
Pentaglobin® |
Human
lgM-enriched Immunoglobulin |
|
 |
|
|
Indicated
for: Treatment
of bacterial infections
(concomitantly with
antibiotics), especially
in sepsis caused
by gram-negative
bacteria and their
toxins. Immunoglobulin
substitution in
immunosuppressed
patients and severe
secondary antibody
deficiency syndrome. |
|
More... |
|
|
|
|
Cytotect®
Biotest |
Human
Immunoglobulin Against Cytomegalovirus |
|
 |
|
|
Indicated
for :
Protection against
cytomegalovirus
infection, especially
in transplant recipients |
| |
| |
|
More... |
|
|
|
| Varitect®
CP |
Human
Immunoglobulin Against Varicella
Zoster |
|
 |
|
|
Indicated
for :
Protection against
chickenpox infection
and treatment of
zoster disease |
| |
| |
|
More... |
|
|
|
|
Hepatect®
CP |
Human
Immunoglobulin against hepatitis
B |
|
 |
|
|
Indicated
for : - |
|
•
Neonates born to
HbsAg-positive mothers.
|
|
•
For post exposure
prophylaxis in accidental
exposures |
|
•
Reinfection prophylaxis
of HbsAg-positive
liver transplant
patients |
|
More... |
|
|
|
|
Biseko® |
Human
serum protein solution 5% |
|
 |
|
|
Indicated
for :
Protein and immunoglobulin
substitution in
deficiency states,
such as after surgery,
trauma, burns |
| |
| |
|
More... |
|
|
|
 |
|
Haemoctin
SDH®
Factor VIII Biotest SDH |
Human
blood clotting factor VIII |
|
 |
|
|
Indicated
for :
Treatment
and prophylaxis
of bleeding |
|
•
in patients
with haemophilia
A (congenital
factor VIII
deficiency
|
|
|
•
in patients with
acquired factor
VIII deficiency.
Treatment of
haemophiliacs
with antibodies
against factor VIII
(inhibitors). |
|
More... |
|
|
|
|
Human
Albumin Biotest® |
Biotest
Human Albumin 20% low salt
&
Biotest Human Albumin 5% |
|
 |
|
|
Human
Albumin 5% Biotest
isotonicIndicated
for : |
|
•
Substitution therapy
in hypoproteinaemia,
particularly
hypoalbuminaemia.
|
|
•
Volume substitution
in loss of blood
and plasma. |
|
Human
Albumin 20% Biotest
low salt content: |
|
•
Substitution therapy
in hypoproteinaemia,
particularly
hypoalbuminaemia.
|
|
•
In extensive loss
of blood and plasma
for commencing plasma
therapy as
well as accompanying
protein therapy. |
|
More... |
|
|
|
| |
|
|
|
Indicated
for :
Human
factor IX is reliable
prophylaxis in haemophilia
B |
|
|
|
More... |
|
|
|
|
top |
